iOnctura is a series a startup based in Switzerland. 1 investor tracked.
iOnctura is a company founded in 2017 headquartered in Switzerland. Its most recent tracked round is Series B. Brouky records 5 investors associated with the company.
iOnctura is a clinical-stage oncology company that develops next-generation precision cancer therapies. It focuses on innovative treatments for various cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.